NATCO Pharma informs about press release

25 Jul 2022 Evaluate

NATCO Pharma has informed that it enclosed the press release today titled ‘NATCO Announces Approval of its ANDA for Cabazitaxel Intravenous Solution (generic for Jevtana Kit®)’ under Regulation 30 of SEBI (LODR) Regulations 2015 for the information.

The above information is a part of company’s filings submitted to BSE.

Natco Pharma Share Price

831.75 -2.10 (-0.25%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×